Verily

Verily is a precision health company that has developed Verily Pre, an AI-native platform designed to transform healthcare research and patient care. Originally founded as part of Alphabet, Verily focuses on making healthcare more predictive, preventive, and precise through advanced data integration and artificial intelligence capabilities.

The company operates through multiple interconnected solutions: Verily Viewpoint for clinical research operations and real-world evidence generation, Lightpath for personalized care programs, and Verily Me, a consumer-facing health app. Their technology integrates multimodal patient data through FHIR-native data models and applies AI agents and models developed with clinical input. Verily's approach combines expertise from clinicians, informaticists, engineers, data scientists, and regulatory specialists to ensure AI solutions are built for safety and trustworthiness.

Recent initiatives include the Lifelong Health Study, a research registry designed to continuously follow participants on their health journeys, and strategic collaborations with healthcare systems like UCHealth and technology partners like NVIDIA to accelerate AI-powered research and care transformation.

Organizations should consider Verily when they require a comprehensive, AI-first platform for transforming both research operations and care delivery at scale. The company excels in scenarios where integrating real-world data with clinical research, modernizing trial operations, or building precision health programs requires sophisticated AI capabilities backed by strong clinical and regulatory expertise.

Engagement with Verily typically involves platform adoption with ongoing collaboration between the company's interdisciplinary team and the client's clinical, technical, and research stakeholders. Organizations can expect enterprise-grade security, comprehensive compliance support, and access to both technology infrastructure and clinical expertise throughout implementation.

Verily operates exclusively in healthcare, with a precision health focus spanning clinical research, care delivery, and consumer health. The company serves multiple healthcare verticals including health systems, pharmaceutical companies conducting clinical trials, and individual patients through consumer applications. Their platform demonstrates deep healthcare expertise through FHIR-native data architecture, HIPAA compliance across solutions, and clinical validation processes involving licensed clinicians.

Healthcare-specific capabilities include clinical trial site operations management, real-world evidence generation from integrated healthcare data, population health program delivery, and consumer health engagement. The company's interdisciplinary team includes clinicians and regulatory experts who ensure AI solutions meet healthcare-specific safety, privacy, and compliance requirements from concept through deployment.

Ideal clients are large healthcare systems, academic medical centers, pharmaceutical companies, and research institutions with significant research programs or population health initiatives. These organizations have the resources and strategic vision to implement comprehensive platform solutions, possess complex data integration needs across clinical and real-world sources, and require enterprise-grade security and compliance capabilities. Organizations actively pursuing AI-enabled precision health strategies or conducting clinical trials at scale will derive maximum value from Verily's integrated approach.